Skip to main content

MARSHALL FINANCIAL GROUP INC /ADV

Location
DOYLESTOWN, PA
Portfolio Value
Micro $719,783
Diversification
Moderately concentrated
Filing Date
Global Rank
#7,636 / 7,976 ▲ 35
Top Industry
Drug Manufacturers - General 32.3%
3Y Alpha vs SPY
-3.5%
Period ended 9 months ago
Filed Nov 4, 2025 · 7mo
23 quarters · since Mar 2020

Clone Performance

Jun 2023–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
+61.5%
SPY
+76.3%
Annualised alpha
-3.5%
Max drawdown
−16.0%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

14 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025
Top Position
31.4%
+1.4 pts
Top 5
70.1%
−1.8 pts
Top 10
90.2%
−3.9 pts
HHI
1,597
Dec 2022 → Sep 2025 · range 1,544 – 2,679
Moderately concentrated+53

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Sep 30, 2025
Sector % Portfolio Value
Healthcare 36.2% $3,224,223
Technology 28.3% $2,523,561
Financial Services 16.8% $1,498,626
Consumer Defensive 8.1% $719,783
Communication Services 7.9% $700,376
Unclassified 2.7% $242,450

Last Quarter's Activity

Export CSV
Sep 30, 2025 vs Jun 30, 2025

Added To

Positions the filer increased
5 positions
Ticker Δ Shares Shares Value Open

Trimmed

Positions the filer reduced
4 positions
Ticker Δ Shares Shares Value Open

New Positions

Positions the filer opened this quarter
3 positions
Ticker Shares Value Open

Sold Out

Positions the filer fully exited
1 positions
Ticker Shares Value Open

Portfolio Positions

Export CSV View 13F filing
2 positions · $719,783 total · Consumer Defensive only · as of Sep 30, 2025
Ticker Company Shares Value (USD) % of Portfolio History